Revolution Medicines, Inc.

RVMD

Revolution Medicines, Inc.

RVMD

Insider Sentiment (TTM):

Last Purchase:2024-12-05Last Sale:2026-06-24Shares Purchased (TTM):0Shares Sold (TTM):691,868

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:192,688,738Shares Outstanding:198,098,047Institutional Ownership Pct.:97.27%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Biological Products, (No Diagnostic Substances)

AMGN GILD SCLX BIIB MRNA NBIX

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	441	384	217	402	334	543	201	276	288	696	358	380
Marketable Securities Current	1,467	1,642	1,714	1,735	1,769	1,746	1,348	1,315	1,415	1,157	455	529
Accounts Receivable Gross Current	-	-	-	-	-	0	0	0	0	1	0	3
Prepaid Expense And Other Assets Current	60	49	46	39	32	38	30	34	26	25	11	10
Assets Current	1,968	2,075	1,977	2,176	2,135	2,328	1,579	1,625	1,729	1,879	824	922
Property Plant And Equipment Net	31	33	33	33	27	24	25	25	24	23	20	20
Operating Lease Right Of Use Asset	130	132	134	114	116	118	74	75	76	77	53	54
Intangible Assets Net Excluding Goodwill	56	56	56	56	56	57	57	57	57	58	58	58
Goodwill	15	15	15	15	15	15	15	15	15	15	15	15
Restricted Cash Noncurrent	5	5	5	4	4	4	3	3	3	3	2	3
Deposits Assets Noncurrent	35	24	17	-	-	12	-	-	-	-	-	-
Other Assets Noncurrent	14	15	15	31	13	2	10	8	4	7	11	3
Assets	2,254	2,355	2,252	2,430	2,365	2,558	1,763	1,808	1,908	2,062	984	1,074
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	81	65	75	57	48	54	24	29	32	62	30	30
Operating Lease Liability Current	17	16	16	13	13	13	8	8	8	7	6	6
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	0	0	0
Liabilities Current	290	290	246	185	159	164	111	105	94	144	86	78
Deferred Income Tax Liabilities Net	2	2	2	2	2	2	3	3	3	3	3	7
Operating Lease Liability Noncurrent	140	142	142	120	121	123	78	79	80	81	57	58
Accrued Royalties Current And Noncurrent	281	268	257	245	-	0	-	-	-	-	-	-
Other Liabilities Noncurrent	7	1	2	7	4	1	2	1	3	1	1	0
Liabilities	754	723	655	564	287	293	197	190	183	236	147	143
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	4,823	4,497	4,098	4,063	4,028	4,002	3,106	3,008	2,980	2,963	1,814	1,800
Accumulated Other Comprehensive Income Loss Net Of…	-1	3	3	1	2	1	4	-2	-1	1	-1	-1
Retained Earnings Accumulated Deficit	-3,323	-2,869	-2,504	-2,199	-1,951	-1,738	-1,543	-1,387	-1,254	-1,138	-976	-868
Stockholders Equity	1,500	1,631	1,597	1,865	2,078	2,265	1,566	1,619	1,725	1,826	837	931
Liabilities And Stockholders Equity	2,254	2,355	2,252	2,430	2,365	2,558	1,763	1,808	1,908	2,062	984	1,074
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	200	197	190	187	186	186	173	171	170	170	109	109
Shares Outstanding	200	197	190	187	186	186	168	166	165	165	109	109

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.24%	20.53%	-	-	-	-	-	-	-	-	-	-
2025	4.62%	-1.99%	0.65%	3.55%	19.77%	48.57%	31.04%	36.08%	98.23%	-7.23%	43.97%	41.09%
2024	0.05%	1.31%	21.22%	0.85%	4.49%	9.82%	-2.64%	-25.60%	-31.02%	-5.90%	-9.23%	-2.37%
2023	4.62%	9.45%	5.20%	16.18%	-8.25%	-38.32%	13.74%	33.15%	28.83%	1.61%	14.94%	29.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	6.80	7.14	8.05	11.79	13.46	14.20	14.24	15.42	18.45	13.06	9.64	11.81
Quick Ratio	6.59	6.97	7.86	11.58	13.26	13.97	13.98	15.10	18.18	12.89	9.51	11.68
Working Capital	1.68B	1.78B	1.73B	1.99B	1.98B	2.16B	1.47B	1.52B	1.64B	1.74B	738.93M	844.03M
Leverage & Debt
Debt to Equity	0.50	0.44	0.41	0.30	0.14	0.13	0.13	0.12	0.11	0.13	0.18	0.15
Interest Coverage TTM	-38.07	-48.80	-90.75	-	-	-	-	-	-	-	-	-
Debt Ratio	0.33	0.31	0.29	0.23	0.12	0.11	0.11	0.10	0.10	0.11	0.15	0.13
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.03	0.03
Per Share Metrics
Diluted EPS TTM	-6.92	-5.95	-5.08	-4.31	-3.71	-3.58	-3.40	-3.14	-2.94	-3.86	-3.03	-2.77
Free Cash Flow Per Share TTM	-5.41	-4.81	-4.11	-3.71	-3.20	-3.38	-3.30	-3.15	-2.78	-3.17	-2.75	-2.36
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-88,031.94%	-80,961.32%	-12,108.78%	-4,207.12%	-1,409.78%	-1,091.30%
Net Profit Margin TTM	-	-	-	-	-	-	-76,423.32%	-69,973.99%	-10,606.04%	-3,768.28%	-1,266.19%	-1,003.36%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-97.16%	-97.49%	-86.89%	-67.27%	-11.32%	8.33%
Net Income Growth (1Y)	96.66%	88.52%	69.47%	56.40%	44.03%	37.52%	71.14%	75.27%	86.87%	75.46%	35.31%	31.96%
EPS Growth (1Y)	86.78%	66.32%	49.42%	36.96%	26.11%	-7.23%	12.05%	13.44%	7.58%	25.02%	4.91%	-8.29%
Valuation Metrics
P/E TTM	-14.04	-13.39	-9.20	-8.54	-9.54	-12.23	-13.34	-12.34	-10.96	-7.44	-9.13	-9.65
P/B TTM	12.84	9.28	5.53	3.72	3.20	3.24	4.83	3.96	3.08	1.78	3.61	3.07
P/S TTM	-	-	-	-	-	-	10,197.27	8,637.68	1,162.77	280.24	115.54	96.84
Market Cap	19.27B	15.14B	8.84B	6.94B	6.65B	7.34B	7.57B	6.41B	5.31B	3.25B	3.02B	2.86B
Enterprise Value	18.82B	14.76B	8.61B	6.54B	6.32B	6.79B	7.37B	6.13B	5.02B	2.55B	2.67B	2.48B
Calculated Values
Free Cash Flow TTM	-1.07B	-913.73M	-777.08M	-700.36M	-601.72M	-567.74M	-551.11M	-520.21M	-457.88M	-358.30M	-300.09M	-252.32M
Net Debt	-440.94M	-383.75M	-222.30M	-402.44M	-333.55M	-543.06M	-201.26M	-278.74M	-291.46M	-699.18M	-358.40M	-382.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-24Sale

Owner: Anders, Jack

Title: Chief Financial Officer

Shares: 20,000

Price/Share: $168.78

Value: $3,375,600.00

Shares Owned: 123,269

Relationship: Officer

Ownership: Direct

2026-06-17Sale

Owner: Horn, Margaret A

Title: Chief Operating Officer

Shares: 29,600

Price/Share: $160.12

Value: $4,739,552.00

Shares Owned: 154,647

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Cislini, Jeff

Title: General Counsel

Shares: 2,157

Price/Share: $156.12

Value: $336,750.84

Shares Owned: 56,521

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Goldsmith, Mark A

Title: See Remarks

Shares: 10,020

Price/Share: $156.12

Value: $1,564,322.40

Shares Owned: 267,330

Relationship: Director,Officer

Ownership: Direct

2026-06-16Sale

Owner: Anders, Jack

Title: Chief Financial Officer

Shares: 2,722

Price/Share: $156.12

Value: $424,958.64

Shares Owned: 123,269

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-24	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	20,000	168.78	$3,375,600.00	123,269	4
2026-06-17	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	29,600	160.12	$4,739,552.00	154,647	4
2026-06-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,157	156.12	$336,750.84	56,521	4
2026-06-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	10,020	156.12	$1,564,322.40	267,330	4
2026-06-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,722	156.12	$424,958.64	123,269	4
2026-06-16	Mancini, Anthony	Officer	See Remarks	Direct	Sale	4,615	156.12	$720,493.80	49,975	4
2026-06-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	4,175	156.12	$651,801.00	291,876	4
2026-06-11	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	10,000	147.32	$1,473,200.00	158,222	4
2026-05-26	Mancini, Anthony	Officer	See Remarks	Direct	Sale	3,121	154.06	$480,821.26	54,400	4
2026-04-27	Mancini, Anthony	Officer	See Remarks	Direct	Sale	3,120	132.96	$414,835.20	54,400	4
2026-04-15	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	120,000	150.09	$18,010,800.00	276,698	4
2026-03-25	Mancini, Anthony	Officer	See Remarks	Direct	Sale	37,450	95.30	$3,568,985.00	54,400	4
2026-03-19	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,163	97.44	$113,322.72	58,518	4
2026-03-17	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	12,871	99.48	$1,280,407.08	276,698	4
2026-03-17	Wang, Xiaolin	Officer	See Remarks	Direct	Sale	2,010	99.48	$199,954.80	116,063	4
2026-03-17	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,753	99.48	$273,868.44	125,512	4
2026-03-17	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	4,302	99.48	$427,962.96	295,398	4
2026-03-17	Wei, Lin	Officer	Chief Medical Officer	Direct	Sale	2,073	99.48	$206,222.04	101,366	4
2026-03-17	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,583	99.48	$455,916.84	157,570	4
2026-03-02	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	30,000	100.49	$3,014,700.00	289,569	4
2026-01-21	Cislini, Jeff	Officer	General Counsel	Direct	Sale	908	115.60	$104,964.80	46,976	4
2026-01-07	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	10,000	98.00	$980,000.00	108,065	4
2026-01-07	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	75,000	101.57	$7,617,750.00	141,053	4
2025-12-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,847	76.82	$372,346.54	141,053	4
2025-12-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	3,104	77.09	$239,287.36	108,065	4
2025-12-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,688	76.82	$206,492.16	47,884	4
2025-12-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	15,394	76.82	$1,182,567.08	232,469	4
2025-12-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	5,447	76.82	$418,438.54	278,600	4
2025-11-25	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	5,418	74.00	$400,932.00	110,994	4
2025-11-25	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	60,000	75.08	$4,504,800.00	247,863	4
2025-11-18	Cislini, Jeff	Officer	General Counsel	Direct	Sale	13,388	70.14	$939,034.32	50,425	4
2025-11-18	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	20,000	70.38	$1,407,600.00	247,863	4
2025-11-12	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	20,000	65.07	$1,301,400.00	247,863	4
2025-11-11	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	10,000	64.00	$640,000.00	110,994	4
2025-11-07	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	30,000	60.31	$1,809,300.00	347,863	4
2025-10-17	Cislini, Jeff	Officer	General Counsel	Direct	Sale	12,000	55.00	$660,000.00	50,425	4
2025-10-17	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	10,000	55.00	$550,000.00	452,309	4
2025-10-13	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	25,000	48.54	$1,213,500.00	284,047	4
2025-09-24	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,799	44.26	$79,623.74	50,425	4
2025-09-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,775	45.82	$218,790.50	145,900	4
2025-09-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	5,367	45.82	$245,915.94	284,047	4
2025-09-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	13,411	45.82	$614,492.02	452,309	4
2025-09-16	Wei, Lin	Officer	Chief Medical Officer	Direct	Sale	2,160	45.82	$98,971.20	88,339	4
2025-09-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,869	45.82	$85,637.58	52,224	4
2025-09-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,320	45.82	$106,302.40	110,994	4
2025-09-15	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	25,000	46.42	$1,160,500.00	289,414	4
2025-09-03	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	5,238	40.17	$210,410.46	113,314	4
2025-06-20	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,912	39.61	$75,734.32	54,093	4
2025-06-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,170	39.83	$86,431.10	113,314	4
2025-06-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	13,496	39.83	$537,545.68	428,720	4
2025-06-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,878	39.83	$74,800.74	56,005	4
2025-06-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	3,510	39.83	$139,803.30	150,675	4
2025-06-16	Wei, Lin	Officer	Chief Medical Officer	Direct	Sale	2,173	39.83	$86,550.59	90,499	4
2025-06-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	4,289	39.83	$170,830.87	289,414	4
2025-03-20	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,041	38.71	$79,007.11	57,723	4
2025-03-17	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	3,058	39.04	$119,384.32	153,533	4
2025-03-17	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	3,294	39.04	$128,597.76	293,051	4
2025-03-17	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,458	39.04	$56,920.32	59,764	4
2025-03-17	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	11,738	39.04	$458,251.52	441,564	4
2025-03-17	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	1,864	39.04	$72,770.56	115,006	4
2025-01-21	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,406	40.50	$97,443.00	39,222	4
2024-12-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	11,714	45.40	$531,815.60	325,056	4
2024-12-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,329	45.40	$196,536.60	127,991	4
2024-12-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,599	45.40	$72,594.60	41,628	4
2024-12-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	4,663	45.40	$211,700.20	259,745	4
2024-12-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,635	45.40	$119,629.00	96,470	4
2024-12-05	Schroeder, Thilo	Director	-	Indirect	Purchase	1,304,347	46.00	$59,999,962.00	2,096,612	4
2024-11-15	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,554	55.13	$140,802.02	43,080	4
2024-11-13	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,666	58.97	$982,794.02	264,408	4
2024-11-06	Cislini, Jeff	Officer	General Counsel	Direct	Sale	6,000	60.00	$360,000.00	45,634	4
2024-11-04	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	50,900	55.56	$2,828,004.00	300,170	4
2024-10-31	Patel, Sushil	Director	-	Direct	Sale	5,000	54.14	$270,700.00	19,948	4
2024-10-14	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,666	49.73	$828,800.18	264,408	4
2024-10-11	Cislini, Jeff	Officer	General Counsel	Direct	Sale	6,000	50.17	$301,020.00	45,634	4
2024-10-11	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	50,000	50.34	$2,517,000.00	132,320	4
2024-10-11	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	30,000	50.36	$1,510,800.00	300,170	4
2024-10-11	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	10,000	50.30	$503,000.00	98,932	4
2024-10-08	Weber, Barbara	Director	-	Direct	Sale	5,200	48.02	$249,704.00	13,065	4
2024-10-01	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	10,000	45.13	$451,300.00	300,170	4
2024-09-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,331	44.19	$191,386.89	132,320	4
2024-09-16	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,454	44.19	$64,252.26	45,634	4
2024-09-16	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	2,244	44.19	$99,162.36	98,932	4
2024-09-16	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	11,715	44.19	$517,685.85	300,170	4
2024-09-16	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	4,665	44.19	$206,146.35	264,408	4
2024-09-13	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,667	43.20	$720,014.40	269,073	4
2024-08-13	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,667	42.98	$716,347.66	269,073	4
2024-08-01	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	10,000	46.04	$460,400.00	311,885	4
2024-07-15	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,667	46.02	$767,015.34	269,073	4
2024-07-12	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	25,000	45.05	$1,126,250.00	311,885	4
2024-07-09	Patel, Sushil	Director	-	Direct	Sale	2,155	44.00	$94,820.00	19,948	4
2024-07-09	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,399	40.83	$97,951.17	47,088	4
2024-06-26	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,000	38.47	$76,940.00	49,487	4
2024-06-25	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,467	39.06	$643,201.02	269,073	4
2024-06-17	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,757	37.39	$65,694.23	51,487	4
2024-06-17	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	1,893	37.39	$70,779.27	101,176	4
2024-06-17	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	3,349	37.39	$125,219.11	269,073	4
2024-06-17	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	4,415	37.39	$165,076.85	136,651	4
2024-06-17	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	11,950	37.39	$446,810.50	311,885	4
2024-06-17	Wei, Lin	Officer	Chief Medical Officer	Direct	Sale	5,589	37.39	$208,972.71	70,851	4
2024-06-03	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	7,500	40.00	$300,000.00	322,322	4
2024-05-21	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,500	39.09	$58,635.00	52,874	4
2024-05-03	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	10,000	40.03	$400,300.00	101,959	4
2024-04-10	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	7,500	35.48	$266,100.00	452,879	4
2024-04-10	Patel, Sushil	Director	-	Direct	Sale	2,155	37.00	$79,735.00	15,700	4
2024-03-27	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,500	30.95	$46,425.00	54,374	4
2024-03-18	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	2,914	31.58	$92,024.12	139,553	4
2024-03-18	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	2,123	31.58	$67,044.34	270,909	4
2024-03-18	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,252	31.58	$39,538.16	55,874	4
2024-03-18	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	5,788	31.58	$182,785.04	460,379	4
2024-03-18	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	1,261	31.58	$39,822.38	101,959	4
2024-03-12	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	7,936	34.07	$270,379.52	142,467	4
2024-01-22	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,500	27.00	$40,500.00	36,126	4
2024-01-08	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	3,337	29.01	$96,806.37	221,632	4
2024-01-02	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	13,330	29.10	$387,903.00	224,969	4
2023-12-27	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	33,334	29.01	$967,019.34	238,299	4
2023-12-18	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	2,088	25.90	$54,079.20	271,633	4
2023-12-18	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	2,993	25.90	$77,518.70	101,467	4
2023-12-18	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,229	25.90	$31,831.10	37,284	4
2023-12-18	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	8,165	25.90	$211,473.50	376,167	4
2023-12-18	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	1,775	25.90	$45,972.50	76,416	4
2023-12-06	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	5,000	25.00	$125,000.00	104,460	4
2023-11-20	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,500	21.70	$32,550.00	38,513	4
2023-10-16	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	25,000	32.87	$821,750.00	96,960	4
2023-10-11	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,667	29.05	$484,176.35	273,721	4
2023-09-28	Cislini, Jeff	Officer	General Counsel	Direct	Sale	2,000	28.58	$57,160.00	40,013	4
2023-09-18	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,214	31.31	$38,010.34	42,013	4
2023-09-18	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	8,054	31.31	$252,170.74	349,332	4
2023-09-18	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	2,514	31.31	$78,713.34	96,960	4
2023-09-18	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	2,060	31.31	$64,498.60	290,388	4
2023-09-18	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	1,427	31.31	$44,679.37	53,667	4
2023-09-01	Anders, Jack	Officer	Chief Financial Officer	Direct	Sale	20,000	35.05	$701,000.00	55,094	4
2023-09-01	Goldsmith, Mark A	Director,Officer	See Remarks	Direct	Sale	30,000	35.05	$1,051,500.00	357,386	4
2023-09-01	Weber, Barbara	Director	-	Direct	Sale	15,000	35.07	$526,050.00	15,825	4
2023-08-31	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	10,000	34.05	$340,500.00	99,474	4
2023-08-15	Horn, Margaret A	Officer	Chief Operating Officer	Direct	Sale	5,000	30.58	$152,900.00	99,474	4
2023-08-02	Kelsey, Stephen Michael	Officer	See Remarks	Direct	Sale	16,666	32.40	$539,978.40	292,448	4
2023-07-31	Cislini, Jeff	Officer	General Counsel	Direct	Sale	1,500	26.02	$39,030.00	43,227	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

97.27%

Inst. Shares: 192,688,738

Shares Outstanding: 198,098,047

2025-12-31

101.63%

Inst. Shares: 193,227,880

Shares Outstanding: 190,129,154

2025-09-30

96.42%

Inst. Shares: 182,454,666

Shares Outstanding: 189,231,562

2025-06-30

95.18%

Inst. Shares: 179,494,039

Shares Outstanding: 188,583,288

2025-03-31

97.00%

Inst. Shares: 182,497,802

Shares Outstanding: 188,145,904

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	192,688,738	198,098,047	97.27%
2025-12-31	193,227,880	190,129,154	101.63%
2025-09-30	182,454,666	189,231,562	96.42%
2025-06-30	179,494,039	188,583,288	95.18%
2025-03-31	182,497,802	188,145,904	97.00%
2024-12-31	184,087,202	167,737,672	109.75%
2024-09-30	160,859,756	166,843,984	96.41%
2024-06-30	162,441,495	165,141,936	98.36%
2024-03-31	153,270,461	164,729,200	93.04%
2023-12-31	147,927,570	113,149,869	130.74%
2023-09-30	103,350,857	109,233,084	94.61%
2023-06-30	98,688,752	106,884,185	92.33%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Revolution Medicines, Inc. (RVMD) — SEC Financial Statements & Analysis

Revolution Medicines, Inc. (RVMD) is a biological products, (no diagnostic substances) company, incorporated in DE. Revolution Medicines, Inc. trades on RVMDW: Nasdaq as: RVMD: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Revolution Medicines, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.50x, a Price-to-Sales (P/S) ratio of 10197.27x (TTM), a Price-to-Book (P/B) ratio of 12.84 (TTM), at a market cap of $19.27B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.50x
P/S TTM: 10197.27x
P/B TTM: 12.84
Market Cap: $19.27B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Revolution Medicines, Inc. in?

Revolution Medicines, Inc. (RVMD) operates in the Biological Products, (No Diagnostic Substances) industry.

What is RVMD's market cap?

Revolution Medicines, Inc. (RVMD) has a market capitalization of $19.27B as of 2026-03-31.

What exchange does RVMD trade on?

Revolution Medicines, Inc. (RVMD) trades on the RVMDW: Nasdaq.

Where is Revolution Medicines, Inc. incorporated?

Revolution Medicines, Inc. is incorporated in DE.

Revolution Medicines, Inc. (RVMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.